Medication Safety and Human Factors |

Skip to main content

Jefferson Libraries Home Academic Commons Home

Medication Safety and Human Factors

Schedule
Subscribe to RSS Feed
2021
9:00 AM	Decreasing Post Insulin Hypoglycemia Incidence in End Stage Renal Disease (ESRD) patients Anna Lo, MD, Thomas Jefferson University Rachana Mundada, MD, Thomas Jefferson University Eric Shiffrin, MD, Thomas Jefferson University Jenny Wang, MD, Thomas Jefferson University 9:00 AM - 5:00 PM
9:00 AM	Evaluating the Efficacy of a Nursing-Driven versus Provider-Driven Heparin Protocol Naman Upadhyay, MD, Thomas Jefferson University Joseph Soucy, MD, Thomas Jefferson University Steven Manobianco, MD, Thomas Jefferson University Samantha Sokoloff, MD, Thomas Jefferson University Sairamya Bodempudi, MD, Thomas Jefferson University Veda Pejaver, MD, Thomas Jefferson University Max Ruge, MD, Thomas Jefferson University Lynda Thomson, PharmD, Thomas Jefferson University Lily Ackermann, MD, Thomas Jefferson University 9:00 AM - 5:00 PM
9:00 AM	Improving Utilization of SGLT2 Inhibitors in the Inpatient Setting Andrea Verghese, MD, Thomas Jefferson University Bharaniabirami Rajaram, MD, Thomas Jefferson University Fred Karaisz, MD, Thomas Jefferson University Jason Ho, MD, Thomas Jefferson University Kaya Patel, MD, Thomas Jefferson University Michael Grodsky, MD, Thomas Jefferson University Shifa Gandhi, MD, Thomas Jefferson University Xuejun Wang, MD, Thomas Jefferson University Yair Lev, MD, Thomas Jefferson University 9:00 AM - 5:00 PM
9:00 AM	Medication Safety in the Operating Room Tzvi Grossman, Thomas Jefferson University Michael Glick, Thomas Jefferson University Alexandra Mulholland, Thomas Jefferson University Febina Padiyath, Thomas Jefferson University Fred Balzer, Thomas Jefferson University 9:00 AM - 5:00 PM
9:00 AM	Outpatient Mineralocorticoid Receptor Antagonist Prescription Rate for Heart Failure Svenja Schneider, MD, Thomas Jefferson University Sairamya Bodempudi, MD, Thomas Jefferson University Joshua Bernard, MD, Thomas Jefferson University Ryan D'Angelo, PharmD, Thomas Jefferson University Eitan Frankel, MD, Thomas Jefferson University Sara Collins, MD, Thomas Jefferson University Yair Lev, MD, Thomas Jefferson University 9:00 AM - 5:00 PM
9:00 AM	Tolerability of Switching Cholinesterase Inhibitors to Memantine Monotherapy Versus Adding Memantine as Combination Therapy for All-Cause Neurodegenerative Disorders Estevana Isaac, MD, Thomas Jefferson University Mijail Serruya, MD, PhD, Thomas Jefferson University Keith Scott, PhD, Thomas Jefferson University Michael R. Sperling, MD, Thomas Jefferson University Carol Lippa, MD, Thomas Jefferson University 9:00 AM - 5:00 PM